I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in..:
Bardia, Aditya
;
Jhaveri, Komal
;
Kalinsky, Kevin
...
Future Oncology. , 2023
Link:
https://hdl.handle.net/10371/195821
RT Journal T1
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2-breast cancer
UL https://suche.suub.uni-bremen.de/peid=base-ftseoulnuniv:oai:s-space.snu.ac.kr:10371_195821&Exemplar=1&LAN=DE A1 Bardia, Aditya A1 Jhaveri, Komal A1 Kalinsky, Kevin A1 Pernas, Sonia A1 Tsurutani, Junji A1 Xu, Binghe A1 Hamilton, Erika A1 Im, Seock-Ah A1 Nowecki, Zbigniew A1 Sohn, Joohyuk A1 De Laurentiis, Michelino A1 Martinez Janez, Noelia A1 Adamo, Barbara A1 Lee, Keun Seok A1 Jung, Kyung Hae A1 Rubovszky, Gabor A1 Tseng, Ling-Ming A1 Lu, Yen-Shen A1 Yuan, Yuan A1 Maxwell, Micah J A1 Haddad, Vincent A1 Khan, Sabrina S A1 Rugo, Hope S A1 Pistilli, Barbara PB Future Medicine Ltd. YR 2023 K1 ANTIBODY-DRUG CONJUGATE K1 TRASTUZUMAB DERUXTECAN K1 DS-8201A K1 RIBOCICLIB K1 GUIDELINE K1 ERIBULIN K1 THERAPY K1 antibody-drug conjugate (ADC) K1 datopotamab deruxtecan (Dato-DXd) K1 HR-positive K1 HER2-negative K1 inoperable breast cancer K1 metastatic breast cancer K1 Trophoblast cell surface antigen 2 (TROP2) JF Future Oncology LK http://dx.doi.org/https://hdl.handle.net/10371/195821 DO https://hdl.handle.net/10371/195821 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)